DUBLIN, Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced that it has commenced construction of a manufacturing and development facility to be located on a 17-acre site in Monksland, County Roscommon, approximately 75 miles east of the company's Dublin headquarters. This is the first manufacturing facility to be built by Jazz Pharmaceuticals.
"Today marks a milestone for Jazz Pharmaceuticals as we break ground in Ireland and begin, for the first time, construction on a manufacturing and development facility," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals plc. "This investment not only strengthens our international manufacturing capabilities, but importantly represents our commitment to expanding our presence in Ireland. We are grateful for the partnership of Ireland's Industrial Development Authority and Roscommon County Council who helped make this project possible."
Members of the Board of Directors and employees of Jazz Pharmaceuticals were joined by the Taoiseach (Prime Minister) of Ireland, Mr. Enda Kenny TD and Mr. Barry O'Leary, CEO, Ireland's Industrial Development Authority (IDA Ireland), during a ground-breaking ceremony today. At the ceremony, Mr. Cozadd outlined the company's plans to commence construction immediately, with an anticipated completion date in 2016. Jazz Pharmaceuticals expects to invest approximately $60 – $68 million (€45 – €50 million) in construction, development and personnel costs to build and open the 55,000 ft2 (5,100 m2) facility. The investment is being supported by the Irish Government's Department of Jobs, Enterprise and Innovation through IDA Ireland.
"I'm delighted to be here for the ground-breaking of Jazz Pharmaceuticals' new manufacturing facility in Roscommon. This is a great boost for the local area and the 160 jobs being created in the construction phase will provide an opportunity for some of those people who lost jobs in this sector in recent years. The new facility will also create up to 50 new jobs when operating at full capacity," said the Taoiseach, Mr. Enda Kenny TD during the ground-breaking ceremony. "I welcome the decision by Jazz Pharmaceuticals to locate in Ireland which is a vote of confidence in our economy and Government policy, like the Action Plan for Jobs, which is targeted towards supporting sectors with the greatest potential to generate jobs."
"Jazz Pharmaceuticals' decision to build a manufacturing site in Ireland is testament to the excellent reputation Ireland has as a global location for biopharmaceutical development and manufacturing," said Mr. Barry O'Leary, CEO IDA Ireland. "This is a strategically important development for Jazz Pharmaceuticals and Ireland is well placed to support manufacturing for the company's growing commercial portfolio."
Messer plans further growth in Western Europe with new industrial gases plant in Spain
Messer, announced the construction of a new production plant for gases at its Spanish location in Vila-seca. It will be located in the south of the Tarragona Chemical Complex and will have a capac...
Loop and Suez to build first infinite Loop™ facility producing 100% recycled and infinitely recyclable plastic in europe
Loop and Suez announce plans to build the first Infinite Loop™ recycling facility in Europe. Based on enhanced recycling, the partnership will combine the resource management expertise of SUEZ and ...
Investment in nickel expansion at Boliden Harjavalta
Boliden invests EUR 40 m in an expansion of its nickel operations at Boliden Harjavalta. The investment will mainly be implemented in 2021.
Repsol invests in its plant in Tarragona, Spain to expand its polymer range
The industrial complex in Tarragona will adapt one of its units to manufacture these advanced materials. The project has a budget of approximately 32 million euros, earmarked for new investments an...